Your browser is no longer supported. Please, upgrade your browser.
Settings
GRFS Grifols, S.A. daily Stock Chart
GRFS [NASD]
Grifols, S.A.
Index- P/E48.68 EPS (ttm)0.48 Insider Own- Shs Outstand700.59M Perf Week-0.04%
Market Cap16.23B Forward P/E17.42 EPS next Y1.33 Insider Trans- Shs Float- Perf Month8.52%
Income- PEG3.63 EPS next Q0.31 Inst Own67.02% Short Float- Perf Quarter14.19%
Sales4.99B P/S3.25 EPS this Y17.80% Inst Trans- Short Ratio1.64 Perf Half Y9.19%
Book/sh3.05 P/B7.60 EPS next Y11.80% ROA- Target Price23.20 Perf Year50.36%
Cash/sh- P/C- EPS next 5Y13.40% ROE- 52W Range14.33 - 24.20 Perf YTD44.18%
Dividend0.33 P/FCF- EPS past 5Y15.13% ROI- 52W High-4.26% Beta-
Dividend %1.42% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low61.69% ATR0.48
Employees12615 Current Ratio- Sales Q/Q13.90% Oper. Margin- RSI (14)58.02 Volatility1.48% 2.10%
OptionableYes Debt/Eq- EPS Q/Q3.40% Profit Margin- Rel Volume0.39 Prev Close23.20
ShortableYes LT Debt/Eq- EarningsNov 14 BMO Payout- Avg Volume664.82K Price23.17
Recom2.00 SMA201.58% SMA505.83% SMA20013.16% Volume259,521 Change-0.13%
Oct-31-17Initiated Citigroup Buy
Jun-30-17Downgrade Goldman Buy → Neutral
Apr-06-17Initiated BofA/Merrill Buy
Jan-03-17Upgrade JP Morgan Neutral → Overweight
Feb-09-16Upgrade Berenberg Hold → Buy
Jan-04-16Downgrade Morgan Stanley Equal-Weight → Underweight
Dec-02-15Downgrade HSBC Securities Buy → Hold
Nov-20-15Downgrade Berenberg Buy → Hold
Apr-28-15Downgrade Berenberg Buy → Hold
Nov-16-17 11:39AM  ETFs with exposure to Grifols SA : November 16, 2017 Capital Cube
Nov-02-17 12:11PM  ETFs with exposure to Grifols SA : November 2, 2017 Capital Cube
Oct-31-17 03:00AM  Stocks Showing Rising Market Leadership: Grifols Earns 83 RS Rating Investor's Business Daily +5.35%
Oct-23-17 10:40AM  ETFs with exposure to Grifols SA : October 23, 2017 Capital Cube
Oct-10-17 11:29AM  ETFs with exposure to Grifols SA : October 10, 2017 Capital Cube
Oct-09-17 09:51AM  Grifols SA :GRFS-US: Earnings Analysis: Q2, 2017 By the Numbers : October 9, 2017 Capital Cube
Sep-20-17 09:30AM  Should Value Investors Consider Grifols (GRFS) Stock Now? Zacks
Sep-13-17 11:25AM  3 Pharma/Biotech Sector Bargains for a Healthy Portfolio Zacks
Sep-06-17 03:00AM  Grifols Shows Market Leadership With Jump To 82 RS Rating Investor's Business Daily
Aug-29-17 12:31PM  Grifols Is a Leader in High-Demand Plasma GuruFocus.com
Aug-28-17 03:00AM  Stocks Flashing Renewed Technical Strength: Grifols Investor's Business Daily
Aug-22-17 08:00AM  Grifols Phocus Rx® Pharmacy Workflow Management Solution Now Integrates With Top Hospital Information Systems via HL7 Interfaces PR Newswire
Aug-01-17 08:00AM  Select American Red Cross Blood Donations Screened for Babesia Parasite Using Grifols' Procleix Babesia Assay Under an Investigational New Drug Protocol PR Newswire
Jun-22-17 03:11PM  Grifols Continues to Strengthen its Diagnostic Division by Launching New Global Testing Services for the Measurement of Biological Drug Levels and Anti-Drug Immune Response in Blood Samples PR Newswire
Jun-21-17 03:48PM  When 'New' Means A Stock Hasn't Led The Market In A While Investor's Business Daily
Jun-16-17 09:55AM  Should Value Investors Consider Grifols (GRFS) Stock Right Now? Zacks
Jun-12-17 04:00AM  Grifols and Beckman Coulter Enter into an Exclusive Distribution Agreement PR Newswire
May-31-17 11:02AM  Grifols SA : GRFS-US: Dividend Analysis : June 01st, 2017 (record date) : By the numbers : May 31, 2017 Capital Cube
May-10-17 04:45PM  Hologic Smashes Fiscal Q2 Sales Views, Beats On Profit By 4 Cents Investor's Business Daily
May-09-17 10:00AM  Investigational New Drug Application is Now Effective for Babesia Screening in Blood Donations Using Grifols Procleix Panther System in the US PR Newswire
May-04-17 10:37AM  VIVUS (VVUS) Loss Narrower than Expected, Revenues Up Y/Y Zacks
Apr-27-17 04:37PM  Glaxo (GSK) Reports In-Line Q1 Earnings, Reiterates View Zacks
11:11AM  Celgene (CELG) Tops on Q1 Earnings, Sales Miss, Raises View Zacks
Apr-24-17 08:00AM  Grifols Strengthens Position as Global Provider of Diagnostic Testing Solutions with Five-Year Extension of OraSure Technologies Agreement and a New Manufacturing Facility PR Newswire
Apr-20-17 10:30AM  Nivalis' (NVLS) Shares Down After Merger Deal with Alpine Zacks
08:15AM  GENOCEA BIOSCIENCES (GNCA) Catches Eye: Stock Gains 7.1% Zacks
Apr-19-17 02:06PM  How to Uncover Institutional Buying Zacks
01:32PM  Can young blood pump new life into treatments for diseases of aging? American City Business Journals
Apr-17-17 09:00AM  Grifols Donates 140 Million International Units of Blood Clotting Factors to the World Federation of Hemophilia Humanitarian Aid Program PR Newswire
Apr-05-17 11:20AM  Amgen Files for Xgeva Label Expansion, To Include Myeloma Zacks
11:20AM  Amgen Files for Xgeva Label Expansion, To Include Myeloma
Apr-04-17 09:19AM  Sanofi's (SNY) Diabetes Drug Toujeo Lowers Hypoglycemia Risk Zacks
09:11AM  Grifols 2016 Annual Report on Form 20-F filed with the SEC on April 4, 2017 PR Newswire
09:11AM  Grifols 2016 Annual Report on Form 20-F filed with the SEC on April 4, 2017
Apr-01-17 12:12PM  New Breakout Stocks Zacks Rank #1 (Strong Buy) Zacks
12:12PM  New Breakout Stocks Zacks Rank #1 (Strong Buy)
Mar-31-17 08:41AM  AbbVie's (ABBV) Humira Drug Label Update Approved by FDA Zacks
08:41AM  AbbVie's (ABBV) Humira Drug Label Update Approved by FDA
Mar-30-17 10:51AM  New Strong Buy Stocks for March 30th Zacks
10:51AM  New Strong Buy Stocks for March 30th
Mar-28-17 08:15AM  Catalyst Pharmaceuticals (CPRX) Jumps: Stock Gains 18.2% Zacks
08:15AM  Catalyst Pharmaceuticals (CPRX) Jumps: Stock Gains 18.2%
Mar-22-17 08:19AM  5 Cheap PEG Picks for Value Investors Right Now
Mar-21-17 02:58PM  Allergan's Dermal Filler for Wrinkle Correction Gets FDA Nod Zacks
02:58PM  Allergan's Dermal Filler for Wrinkle Correction Gets FDA Nod
Mar-20-17 10:32AM  AstraZeneca (AZN) Gets Another CRL for ZS-9; Inks COPD Deal Zacks
10:32AM  AstraZeneca (AZN) Gets Another CRL for ZS-9; Inks COPD Deal
Mar-17-17 09:50AM  Is Grifols a Great Stock for Value Investors?
Mar-10-17 08:15AM  Aurinia (AUPH) Catches Eye: Stock Moves up 8.5% in Session
Mar-09-17 09:27AM  New Strong Buy Stocks for March 9th
08:15AM  Esperion Therapeutics (ESPR) Jumps: Stock Moves Up 8.6%
Mar-07-17 05:48PM  5 European Stocks to Buy as Trump Rally Weakens
Mar-06-17 12:24PM  Grifols SA :GRFS-US: Earnings Analysis: 2016 By the Numbers : March 6, 2017
Mar-03-17 10:46AM  Grifols SA :GRFS-US: Earnings Analysis: Q4, 2016 By the Numbers : March 3, 2017
Mar-02-17 08:15AM  Blog Coverage Kite Pharma CAR-T Cancer Therapy Demonstrate Positive Results in B-cell non-Hodgkin Lymphoma Accesswire
Jan-31-17 04:05PM  Grifols closes the acquisition of Hologic's share of NAT donor screening unit for USD 1,850 million PR Newswire
04:01PM  Hologic Completes Divestiture of Blood Screening Business PR Newswire
Jan-30-17 12:26PM  Grifols SA : GRFS-US: Dividend Analysis : December 07th, 2016 (record date) : By the numbers : January 30, 2017
Jan-03-17 11:51AM  Grifols, S.A. upgraded by JP Morgan
Dec-19-16 07:46AM  Hologic (HOLX) to Divest Blood Screening Business to Grifols
Dec-15-16 04:42PM  Hologic Still A Buy After Getting 'Lofty' Price For Blood-Screening Unit +6.99%
Dec-14-16 07:14PM  Hologic Agrees to Sell Blood Screening Business to Grifols for $1.85B
04:43PM  Hologic to sell stake in blood screening unit for $1.85 bln at MarketWatch
04:15PM  Grifols agrees to acquire Hologic's share of NAT donor screening unit for USD 1,850 million PR Newswire
04:01PM  Hologic to Divest Blood Screening Business to Partner Grifols for $1.85 Billion PR Newswire
Dec-13-16 12:56PM  ETFs with exposure to Grifols SA : December 13, 2016
Dec-09-16 06:52PM  Virgin America Inc (VA): Is It Right For Your Portfolio? at Insider Monkey
Dec-05-16 06:45AM  Ligand Pharmaceuticals Inc. (LGND): Hedge Fund Sentiment Unchanged at Insider Monkey
Dec-02-16 12:29PM  ETFs with exposure to Grifols SA : December 2, 2016
Dec-01-16 04:29PM  John Paulson's Largest 3rd Quarter Trades
Nov-25-16 10:10PM  What Explains the Huge Jump in Louisiana-Pacific Corporation (LPX)s Hedge Fund Ownership? at Insider Monkey
Nov-11-16 10:11AM  Grifols SA :GRFS-US: Earnings Analysis: Q3, 2016 By the Numbers : November 11, 2016
Oct-20-16 07:37PM  The CLIA Lab at the Grifols Immunohematology Center Will Now Offer Both Serology and Molecular Tests Business Wire
Oct-07-16 11:14AM  Grifols SA : GRFS-US: Dividend Analysis : June 06th, 2016 (record date) : By the numbers : October 7, 2016
Sep-08-16 07:39AM  5 Big Dividend Stocks Billionaire John Paulson Loves
Sep-07-16 07:04PM  Why Is JOHIX Doing So Well Year-to-Date?
Sep-05-16 05:32AM  Grifols Opens Diagnostic Training Center in Dubai PR Newswire
Aug-26-16 04:38PM  New Zika Screening Rule Could Boost Hologic Sales Growth
Aug-25-16 10:16AM  ETFs with exposure to Grifols SA : August 25, 2016
Jul-26-16 11:01AM  Grifols SA :GRFS-US: Earnings Analysis: Q1, 2016 By the Numbers : July 26, 2016
Jul-25-16 01:29PM  ETFs with exposure to Grifols SA : July 25, 2016
Jul-12-16 12:20PM  Grifols SA : GRFS-US: Dividend Analysis : June 06th, 2016 (record date) : By the numbers : July 12, 2016
Jun-30-16 12:08PM  ETFs with exposure to Grifols SA : June 30, 2016
Jun-29-16 02:42PM  Grifols SA : GRFS-US: Dividend Analysis : June 06th, 2016 (record date) : By the numbers : June 29, 2016
Jun-22-16 11:33PM  Grifols SA : GRFS-US: Dividend Analysis : June 06th, 2016 : By the numbers : June 23, 2016
12:54PM  Grifols SA :GRFS-US: Earnings Analysis: Q1, 2016 By the Numbers : June 22, 2016
Jun-20-16 04:31PM  Zika Blood Screening Test From Hologic, Grifols Gets FDA Nod
10:59AM  Hologic And Grifols Get FDA Approval For Procleix Zika Virus Assay
08:00AM  FDA Approves Use of the Procleix Zika Virus Assay from Hologic and Grifols to Screen the U.S. Blood Supply Under an IND Study Protocol PR Newswire
Jun-16-16 09:05AM  Analyzing IBBs Moving Averages
Jun-01-16 09:07AM  Grifols Maintains Its Dividend Payout at 40%
May-31-16 08:26AM  Singulex announces a $50 million investment by Grifols for a 20% stake in the company PR Newswire
May-04-16 04:10PM  ETFs with exposure to Grifols SA : May 4, 2016
Apr-08-16 01:04PM  GRIFOLS SA Financials
Apr-06-16 05:20PM  ETFs with exposure to Grifols SA : April 6, 2016
Apr-05-16 09:35AM  Grifols could receive more than $12M from county if it meets hiring projections at bizjournals.com
07:12AM  Grifols 2015 Annual Report on Form 20-F filed with the SEC on April 5, 2016 PR Newswire
Mar-10-16 01:52PM  ETFs with exposure to Grifols SA : March 10, 2016
Mar-07-16 12:34PM  Grifols SA :GRFS-US: Earnings Analysis: Q4, 2015 By the Numbers
Feb-22-16 12:18PM  5 Health Care Stocks John Paulson Is Betting On for 2016 at TheStreet
Grifols, S.A., a specialty biopharmaceutical company, develops, manufactures, and distributes a range of plasma derivative products primarily in the European Union, Spain, the United States, Canada, and internationally. It specializes in providing infusion solutions, nutrition products, medical devices, and diagnostic instrumentation and reagents for use in hospitals and clinics. The company operates through four divisions: Bioscience, Diagnostic, Hospital, and Raw Materials and Others. The Bioscience division manufactures and sells plasma derivatives for therapeutic use, such as the reception, analysis, quarantine, classification, fractionation, and purification of plasma; and sells and distributes end products. This division offers plasma products, such as IVIG, Factor VIII, A1PI, and albumin; and intramuscular immunoglobulins, ATIII, Factor IX, and plasma thromboplastin components. The Diagnostic division focuses on researching, developing, manufacturing, and marketing in vitro diagnostics products comprising analytical instruments and reagents for diagnostics, as well as blood bank products. This division primarily serves blood donation centers, clinical analysis laboratories, and hospital immunohematology services. The Hospital division manufactures and installs products used by and in hospitals, including parenteral solutions, and enteral and parenteral nutritional fluids. The Raw Materials and Others division is involved in the sale of intermediate pastes and plasma products, as well as provision of engineering services to external companies. The company's products and services are used by healthcare providers to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases, and a range of other medical conditions. Grifols, S.A. was founded in 1940 and is headquartered in Barcelona, Spain.